Digital Pathology Market By Products (Whole Slide Imaging, Image Analysis- Informatics, Information Management System Storage and Communication, Information Management System Storage and Communication), Industry Trends, Estimation & Forecast, 2016 - 2024
Global digital pathology market was valued at $390.7 million in 2016 and is projected to reach $1.3 billion by 2024, having a CAGR of 16.6% during the forecast period of 2017 to 2024. In 2016, whole slide imaging segment held the largest share of the global digital pathology market.
Digital Pathology is a computer aided image-based information environment. It is one of the emerging technology within the field of pathology. Glass slides containing specimens are transformed into digital images for easy analysis, transport and storage. Images which are full of information are stored digitally forming a database related to the patient, helping in quick and accurate diagnosis. Cost effective benefit and enhanced analysis are prime advantages of digital pathology. An upsurge in preferences for computer-aided diagnosis that facilitates efficient disease detection, result evaluation at anatomic level, quantification of disease progression and risk assessment are expected to fuel the market growth.
MARKET DETERMINANTS
Rapidly increasing application within cancer diagnosis is the prime factor attributing to the growth of global digital pathology market. In addition, high efficiency of system, analysis, workflow and ease in transportation and storage also boosts the market growth. Digital pathology has a great significance in the diagnosis of diseases in the remote areas where the conventional methods have low efficacy. However, reluctance towards adoption of digital technology and lack of essential infrastructure in developing countries might act as restrains for the growth of digital pathology market globally. Growing awareness towards digital pathology and expanding applications of digital pathology will offer notable opportunities for global digital pathology market.
MARKET SEGMENTATION
Global digital pathology market is segmented by product, by end user, and region. Product is further segmented as whole slide imaging, image analysis- informatics, information management system storage and communication, and others. By end user the market is categorized as educational institutes, hospitals & diagnostic centers, and pharmaceuticals & biotechnology companies. Geographically, digital pathology market is segmented as North America, Europe, APAC, and ROW. North America garners the largest market share and is expected to grow at a steady CAGR of 13.5% from 2017 to 2024.
Europe is expected to grow at CAGR of 13.4% and is anticipated to contribute 1/4th of the market share in terms of revenue. Russia is expected to lead the market in terms of growth rate with CAGR of 15.7%.
Some notable market players are Danaher Corporation, Digipath Inc., Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, PerkinElmer, Inc., Pixcelldata Ltd. and Visiopharm A/S. Pathcore and Visiopharm announced their partnership to provide enhanced workflow software solutions for quantitative analysis and management of digital pathology images. By leveraging the strengths of Visiopharm, a global industry leader of digital pathology solutions including quantitative image analysis, and Pathcore, a web-based digital pathology software provider, the partnership brings together a broader offering of image analysis and management tools that increase productivity, collaboration and reporting capabilities.
MARKET SEGMENTATION
By Products
Digital Pathology is a computer aided image-based information environment. It is one of the emerging technology within the field of pathology. Glass slides containing specimens are transformed into digital images for easy analysis, transport and storage. Images which are full of information are stored digitally forming a database related to the patient, helping in quick and accurate diagnosis. Cost effective benefit and enhanced analysis are prime advantages of digital pathology. An upsurge in preferences for computer-aided diagnosis that facilitates efficient disease detection, result evaluation at anatomic level, quantification of disease progression and risk assessment are expected to fuel the market growth.
MARKET DETERMINANTS
Rapidly increasing application within cancer diagnosis is the prime factor attributing to the growth of global digital pathology market. In addition, high efficiency of system, analysis, workflow and ease in transportation and storage also boosts the market growth. Digital pathology has a great significance in the diagnosis of diseases in the remote areas where the conventional methods have low efficacy. However, reluctance towards adoption of digital technology and lack of essential infrastructure in developing countries might act as restrains for the growth of digital pathology market globally. Growing awareness towards digital pathology and expanding applications of digital pathology will offer notable opportunities for global digital pathology market.
MARKET SEGMENTATION
Global digital pathology market is segmented by product, by end user, and region. Product is further segmented as whole slide imaging, image analysis- informatics, information management system storage and communication, and others. By end user the market is categorized as educational institutes, hospitals & diagnostic centers, and pharmaceuticals & biotechnology companies. Geographically, digital pathology market is segmented as North America, Europe, APAC, and ROW. North America garners the largest market share and is expected to grow at a steady CAGR of 13.5% from 2017 to 2024.
Europe is expected to grow at CAGR of 13.4% and is anticipated to contribute 1/4th of the market share in terms of revenue. Russia is expected to lead the market in terms of growth rate with CAGR of 15.7%.
Some notable market players are Danaher Corporation, Digipath Inc., Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, PerkinElmer, Inc., Pixcelldata Ltd. and Visiopharm A/S. Pathcore and Visiopharm announced their partnership to provide enhanced workflow software solutions for quantitative analysis and management of digital pathology images. By leveraging the strengths of Visiopharm, a global industry leader of digital pathology solutions including quantitative image analysis, and Pathcore, a web-based digital pathology software provider, the partnership brings together a broader offering of image analysis and management tools that increase productivity, collaboration and reporting capabilities.
MARKET SEGMENTATION
By Products
- Whole Slide Imaging
- Image Analysis- Informatics
- Information Management System Storage and Communication
- Others
- Educational Institutes
- Hospitals & Diagnostic Centers
- Pharmaceuticals and Biotechnology Companies
- North America
- U.S
- Canada
- Mexico
- Europe
- U.K
- Germany
- Spain
- Italy
- France
- Russia
- Others
- Asia-Pacific
- India
- China
- Japan
- Australia
- Taiwan
- South Korea
- Others
- Rest of the World
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- Colombia
- Argentina
- Others
- Danaher Corporation
- Digipath Inc.
- Glencoe Software Inc.
- Hamamatsu Photonics K.K.
- Indica Labs Inc.
- Koninklijke Philips N.V.
- Nikon Corporation
- PerkinElmer, Inc.
- Pixcelldata Ltd.
- Visiopharm A/S
CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
1.2. RESEARCH SUMMARY
CHAPTER 2. MARKET LANDSCAPE
2.1. RESEARCH SCOPE
2.2. VALUE CHAIN ANALYSIS
2.3. FIVE FORCES ANALYSIS
2.4. MARKET SHARE ANALYSIS
2.5. DEMAND FORECAST
2.6. BUSINESS INTELLIGENCE & STRATEGIC ANALYSIS
2.7. MARKET DETERMINANTS
2.7.1. Drivers
2.7.1.1. Application in cancer diagnosis
2.7.1.2. High efficiency of system, analysis and workflow
2.7.1.3. Ease in transportation and storage
2.7.1.4. Significance in remote regions
2.7.2. Restraints
2.7.2.1. Reluctance towards adoption of digital pathology
2.7.2.2. Lack of essential infrastructure in developing countries
2.7.3. Opportunities
2.7.3.1. Evolving awareness towards pertaining digital pathology
2.7.3.2. Increasing application of digital pathology
CHAPTER 3. GLOBAL DIGITAL PATHOLOGY MARKET BY PRODUCT
3.1. SEGMENT OUTLINE
3.2. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024
3.3. WHOLE SLIDE IMAGING
3.3.1. Trend analysis
3.3.2. Market growth indicators
3.3.3. Global whole slide imaging digital pathology market revenue by region,2016-2024
3.4. IMAGE ANALYSIS INFORMATICS
3.4.1. Trend analysis
3.4.2. Market growth indicators
3.4.3. Global image analysis informatics digital pathology market revenue by region,2016-2024
3.5. INFORMATION MANAGEMENT
3.5.1. Trend analysis
3.5.2. Market growth indicators
3.5.3. Global information management digital pathology market revenue by region,2016-2024
3.6. OTHERS
3.6.1. Trend analysis
3.6.2. Market growth indicators
3.6.3. Global others digital pathology market revenue by region,2016-2024
CHAPTER 4. GLOBAL DIGITAL PATHOLOGY MARKET BY END-USER
4.1. SEGMENT OUTLINE
4.2. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY END-USER,2016-2024
4.3. EDUCATIONAL INSTITUTES
4.3.1. Trend analysis
4.3.2. Market growth indicators
4.3.3. Global educational institutes market revenue by region,2016-2024
4.4. HOSPITALS AND DIAGNOSTIC CENTERS
4.4.1. Trend analysis
4.4.2. Market growth indicators
4.4.3. Global hospitals and diagnostics centers market revenue by region,2016-2024
4.5. PHARMACEUTICALS COMPANIES
4.5.1. Trend analysis
4.5.2. Market growth analysis
4.5.3. Global pharmaceuticals companies market revenue by region,2016-2024
CHAPTER 5. GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY
5.1. SEGMENT OUTLINE
5.2. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY GEOGRAPHY,2016-2024
5.3. NORTH AMERICA
5.3.1. Trend analysis
5.3.2. Market growth indicators
5.3.3. North America digital pathology market revenue by product,2016-2024
5.3.4. North America digital pathology market revenue by country,2016-2024
5.3.5. U.S.
5.3.6. Canada
5.3.7. Mexico
5.4. EUROPE
5.4.1. Trend analysis
5.4.2. Market growth indicators
5.4.3. Europe digital pathology market revenue by product,2016-2024
5.4.4. Europe digital pathology market revenue by country,2016-2024
5.4.5. Germany
5.4.6. France
5.4.7. U.K.
5.4.8. Itlay
5.4.9. Spain
5.4.10. Russia
5.4.11. Other
5.5. ASIA-PACIFIC
5.5.1. Trend analysis
5.5.2. Market growth indicators
5.5.3. Asia-Pacific digital pathology market revenue by product,2016-2024
5.5.4. Asia-Pacific digital pathology market revenue by country,2016-2024
5.5.5. Brazil
5.5.6. Turkey
5.5.7. Venezuela
5.5.8. Saudi Arabia
5.5.9. Colombia
5.5.10. Argentina
5.5.11.
CHAPTER 6. KEY VENDOR PROFILES
6.1. PIXCELLDATA LIMITED
6.1.1. Company synopsis
6.1.2. Company snapshot
6.1.3. Business overview
6.1.4. Strategic analysis
6.2. KONINKLIJKE PHILIPS N.V.
6.2.1. Company synopsis
6.2.2. Company snapshot
6.2.3. Business overview
6.2.4. Strategic analysis
6.3. PERKINELMER, INC.
6.3.1. Company synopsis
6.3.2. Company snapshot
6.3.3. Business overview
6.3.4. Strategic analysis
6.4. NIKON CORPORATION
6.4.1. Company synopsis
6.4.2. Company snapshot
6.4.3. Business overview
6.4.4. Strategic analysis
6.5. DIGIPATH, INC.
6.5.1. Company synopsis
6.5.2. Company snapshot
6.5.3. Business overview
6.5.4. Strategic analysis
6.6. GLENCOE SOFTWARE, INC.
6.6.1. Company synopsis
6.6.2. Company snapshot
6.6.3. Business overview
6.6.4. Strategic analysis
6.7. INDICA LABS, INC.
6.7.1. Company synopsis
6.7.2. Company snapshot
6.7.3. Business overview
6.7.4. Strategic analysis
6.8. VISIOPHARM
6.8.1. Company synopsis
6.8.2. Company snapshot
6.8.3. Business overview
6.8.4. Strategic analysis
6.9. DANAHER CORPORATION
6.9.1. Company synopsis
6.9.2. Company snapshot
6.9.3. Business overview
6.9.4. Strategic analysis
6.10. HAMAMATSU PHOTONICS K.K.
6.10.1. Company synopsis
6.10.2. Company snapshot
6.10.3. Business overview
6.10.4. Strategic analysis
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
1.2. RESEARCH SUMMARY
CHAPTER 2. MARKET LANDSCAPE
2.1. RESEARCH SCOPE
2.2. VALUE CHAIN ANALYSIS
2.3. FIVE FORCES ANALYSIS
2.4. MARKET SHARE ANALYSIS
2.5. DEMAND FORECAST
2.6. BUSINESS INTELLIGENCE & STRATEGIC ANALYSIS
2.7. MARKET DETERMINANTS
2.7.1. Drivers
2.7.1.1. Application in cancer diagnosis
2.7.1.2. High efficiency of system, analysis and workflow
2.7.1.3. Ease in transportation and storage
2.7.1.4. Significance in remote regions
2.7.2. Restraints
2.7.2.1. Reluctance towards adoption of digital pathology
2.7.2.2. Lack of essential infrastructure in developing countries
2.7.3. Opportunities
2.7.3.1. Evolving awareness towards pertaining digital pathology
2.7.3.2. Increasing application of digital pathology
CHAPTER 3. GLOBAL DIGITAL PATHOLOGY MARKET BY PRODUCT
3.1. SEGMENT OUTLINE
3.2. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024
3.3. WHOLE SLIDE IMAGING
3.3.1. Trend analysis
3.3.2. Market growth indicators
3.3.3. Global whole slide imaging digital pathology market revenue by region,2016-2024
3.4. IMAGE ANALYSIS INFORMATICS
3.4.1. Trend analysis
3.4.2. Market growth indicators
3.4.3. Global image analysis informatics digital pathology market revenue by region,2016-2024
3.5. INFORMATION MANAGEMENT
3.5.1. Trend analysis
3.5.2. Market growth indicators
3.5.3. Global information management digital pathology market revenue by region,2016-2024
3.6. OTHERS
3.6.1. Trend analysis
3.6.2. Market growth indicators
3.6.3. Global others digital pathology market revenue by region,2016-2024
CHAPTER 4. GLOBAL DIGITAL PATHOLOGY MARKET BY END-USER
4.1. SEGMENT OUTLINE
4.2. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY END-USER,2016-2024
4.3. EDUCATIONAL INSTITUTES
4.3.1. Trend analysis
4.3.2. Market growth indicators
4.3.3. Global educational institutes market revenue by region,2016-2024
4.4. HOSPITALS AND DIAGNOSTIC CENTERS
4.4.1. Trend analysis
4.4.2. Market growth indicators
4.4.3. Global hospitals and diagnostics centers market revenue by region,2016-2024
4.5. PHARMACEUTICALS COMPANIES
4.5.1. Trend analysis
4.5.2. Market growth analysis
4.5.3. Global pharmaceuticals companies market revenue by region,2016-2024
CHAPTER 5. GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY
5.1. SEGMENT OUTLINE
5.2. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY GEOGRAPHY,2016-2024
5.3. NORTH AMERICA
5.3.1. Trend analysis
5.3.2. Market growth indicators
5.3.3. North America digital pathology market revenue by product,2016-2024
5.3.4. North America digital pathology market revenue by country,2016-2024
5.3.5. U.S.
5.3.6. Canada
5.3.7. Mexico
5.4. EUROPE
5.4.1. Trend analysis
5.4.2. Market growth indicators
5.4.3. Europe digital pathology market revenue by product,2016-2024
5.4.4. Europe digital pathology market revenue by country,2016-2024
5.4.5. Germany
5.4.6. France
5.4.7. U.K.
5.4.8. Itlay
5.4.9. Spain
5.4.10. Russia
5.4.11. Other
5.5. ASIA-PACIFIC
5.5.1. Trend analysis
5.5.2. Market growth indicators
5.5.3. Asia-Pacific digital pathology market revenue by product,2016-2024
5.5.4. Asia-Pacific digital pathology market revenue by country,2016-2024
5.5.5. Brazil
5.5.6. Turkey
5.5.7. Venezuela
5.5.8. Saudi Arabia
5.5.9. Colombia
5.5.10. Argentina
5.5.11.
CHAPTER 6. KEY VENDOR PROFILES
6.1. PIXCELLDATA LIMITED
6.1.1. Company synopsis
6.1.2. Company snapshot
6.1.3. Business overview
6.1.4. Strategic analysis
6.2. KONINKLIJKE PHILIPS N.V.
6.2.1. Company synopsis
6.2.2. Company snapshot
6.2.3. Business overview
6.2.4. Strategic analysis
6.3. PERKINELMER, INC.
6.3.1. Company synopsis
6.3.2. Company snapshot
6.3.3. Business overview
6.3.4. Strategic analysis
6.4. NIKON CORPORATION
6.4.1. Company synopsis
6.4.2. Company snapshot
6.4.3. Business overview
6.4.4. Strategic analysis
6.5. DIGIPATH, INC.
6.5.1. Company synopsis
6.5.2. Company snapshot
6.5.3. Business overview
6.5.4. Strategic analysis
6.6. GLENCOE SOFTWARE, INC.
6.6.1. Company synopsis
6.6.2. Company snapshot
6.6.3. Business overview
6.6.4. Strategic analysis
6.7. INDICA LABS, INC.
6.7.1. Company synopsis
6.7.2. Company snapshot
6.7.3. Business overview
6.7.4. Strategic analysis
6.8. VISIOPHARM
6.8.1. Company synopsis
6.8.2. Company snapshot
6.8.3. Business overview
6.8.4. Strategic analysis
6.9. DANAHER CORPORATION
6.9.1. Company synopsis
6.9.2. Company snapshot
6.9.3. Business overview
6.9.4. Strategic analysis
6.10. HAMAMATSU PHOTONICS K.K.
6.10.1. Company synopsis
6.10.2. Company snapshot
6.10.3. Business overview
6.10.4. Strategic analysis
LIST OF TABLES
TABLE NO 1. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 2. GLOBAL WHOLE SLIDE IMAGING DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 3. GLOBAL IMAGE ANALYSIS INFORMATICS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 4. GLOBAL INFORMATION MANAGEMENT DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 5. GLOBAL OTHERS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 6. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY END-USER,2016-2024($MILLION)
TABLE NO 7. GLOBAL EDUCATIONAL INSTITUTES MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 8. GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 9. GLOBAL PHARMACEUTICALS COMPANIES MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 10. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY GEOGRAPHY,2016-2024($MILLION)
TABLE NO 11. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 12. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
TABLE NO 13. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 14. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
TABLE NO 15. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 16. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
TABLE NO 1. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 2. GLOBAL WHOLE SLIDE IMAGING DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 3. GLOBAL IMAGE ANALYSIS INFORMATICS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 4. GLOBAL INFORMATION MANAGEMENT DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 5. GLOBAL OTHERS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 6. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY END-USER,2016-2024($MILLION)
TABLE NO 7. GLOBAL EDUCATIONAL INSTITUTES MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 8. GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 9. GLOBAL PHARMACEUTICALS COMPANIES MARKET REVENUE BY REGION,2016-2024($MILLION)
TABLE NO 10. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY GEOGRAPHY,2016-2024($MILLION)
TABLE NO 11. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 12. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
TABLE NO 13. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 14. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
TABLE NO 15. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
TABLE NO 16. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
LIST OF FIGURES
FIGURE NO 1. VALUE CHAIN ANALYSIS
FIGURE NO 2. FIVE FORCES ANALYSIS
FIGURE NO 3. MARKET SHARE ANALYSIS
FIGURE NO 4. INVESTMENT OPPORTUNITIES
FIGURE NO 5. KEY STRATEGIC ATTEMPTS (%SHARE)
FIGURE NO 6. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 7. GLOBAL WHOLE SLIDE IMAGING DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 8. GLOBAL IMAGE ANALYSIS INFORMATICS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 9. GLOBAL INFORMATION MANAGEMENT DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 10. GLOBAL OTHERS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 11. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY END-USER,2016-2024(MILLION)
FIGURE NO 12. GLOBAL EDUCATIONAL INSTITUTES MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 13. GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 14. GLOBAL PHARMACEUTICALS COMPANIES MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 15. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY GEOGRAPHY,2016-2024($MILLION)
FIGURE NO 16. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 17. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
FIGURE NO 18. U.S. DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 19. CANADA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 20. MEXICO DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 21. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 22. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
FIGURE NO 23.GERMANY DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 24. FRANCE DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 25. U.K. DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 26. ITLAY DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 27. SPAIN DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 28. RUSSIA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 29. OTHER DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 30. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 31. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
FIGURE NO 32. BRAZIL DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 33. TURKEY DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 34. VENEZUELA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 35. SAUDI ARABIA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 36. COLOMBIA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 37. ARGENTINA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 38. OTHER DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 1. VALUE CHAIN ANALYSIS
FIGURE NO 2. FIVE FORCES ANALYSIS
FIGURE NO 3. MARKET SHARE ANALYSIS
FIGURE NO 4. INVESTMENT OPPORTUNITIES
FIGURE NO 5. KEY STRATEGIC ATTEMPTS (%SHARE)
FIGURE NO 6. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 7. GLOBAL WHOLE SLIDE IMAGING DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 8. GLOBAL IMAGE ANALYSIS INFORMATICS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 9. GLOBAL INFORMATION MANAGEMENT DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 10. GLOBAL OTHERS DIGITAL PATHOLOGY MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 11. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY END-USER,2016-2024(MILLION)
FIGURE NO 12. GLOBAL EDUCATIONAL INSTITUTES MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 13. GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 14. GLOBAL PHARMACEUTICALS COMPANIES MARKET REVENUE BY REGION,2016-2024($MILLION)
FIGURE NO 15. GLOBAL DIGITAL PATHOLOGY MARKET REVENUE BY GEOGRAPHY,2016-2024($MILLION)
FIGURE NO 16. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 17. NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
FIGURE NO 18. U.S. DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 19. CANADA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 20. MEXICO DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 21. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 22. EUROPE DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
FIGURE NO 23.GERMANY DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 24. FRANCE DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 25. U.K. DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 26. ITLAY DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 27. SPAIN DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 28. RUSSIA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 29. OTHER DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 30. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY PRODUCT,2016-2024($MILLION)
FIGURE NO 31. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE BY COUNTRY,2016-2024($MILLION)
FIGURE NO 32. BRAZIL DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 33. TURKEY DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 34. VENEZUELA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 35. SAUDI ARABIA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 36. COLOMBIA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 37. ARGENTINA DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
FIGURE NO 38. OTHER DIGITAL PATHOLOGY MARKET REVENUE,2016-2024($MILLION)
